Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CureVac (CVAC) Profit After Tax (2019 - 2025)

Historic Profit After Tax for CureVac (CVAC) over the last 7 years, with Q3 2025 value amounting to $319.4 million.

  • CureVac's Profit After Tax fell 1396.0% to $319.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 3161.21%. This contributed to the annual value of $173.3 million for FY2024, which is 16191.36% up from last year.
  • CureVac's Profit After Tax amounted to $319.4 million in Q3 2025, which was down 1396.0% from -$67.4 million recorded in Q2 2025.
  • In the past 5 years, CureVac's Profit After Tax registered a high of $371.2 million during Q3 2024, and its lowest value of -$183.1 million during Q2 2021.
  • Its 5-year average for Profit After Tax is -$34.3 million, with a median of -$61.6 million in 2023.
  • Its Profit After Tax has fluctuated over the past 5 years, first crashed by 39466081.03% in 2021, then soared by 80054.67% in 2024.
  • CureVac's Profit After Tax (Quarter) stood at -$2.2 million in 2021, then crashed by 5832.63% to -$131.4 million in 2022, then rose by 29.04% to -$93.2 million in 2023, then surged by 62.45% to -$35.0 million in 2024, then surged by 1012.41% to $319.4 million in 2025.
  • Its last three reported values are $319.4 million in Q3 2025, -$67.4 million for Q2 2025, and -$54.8 million during Q1 2025.